All current DZIF news can be found here.

Three young researchers, (left) Prof. Jan Heyckendorf, (centre) Maya Reimann (both DZIF), (right) Dr. Sebastian Marwitz (DZL), are the joint recipients of the Award for Clinical Research of the German Society of Pneumology.
© Medizinische Klinik Borstel; Privat; Privat

Clinical Research Award for DZIF and DZL tuberculosis researchers

This year's Award for Clinical Research of the German Society of Pneumology and Respiratory Medicine (DGP) went to a group of three young researchers from two German Centers for Health Research. Maja

Transmission electron microscopic image of HIV particles in co-culture with lymphocytes
© A Harrison, P Feorino, EL Palmer / CDC

New insights on the path to curing chronic HIV infections

AIDS, an immunodeficiency disease caused by infection with the human immunodeficiency virus (HIV), is one of the ten leading causes of death worldwide. Thanks to antiviral therapies, the disease can

Logo des DNAMR in weiß auf einem elektronenmikroskopischen Bild von Pneumokokken
© CDC/Meredith Newlove

German network against antimicrobial resistance launched

New antibiotics are urgently needed to counter the rapidly increasing spread of resistance. The German Network against Antimicrobial Resistance (DNAMR) was founded to promote the development of new

Electron microscopic image of several cells of the pathogenic bacterium Staphylococcus aureus. The spheric bacterial cells are coloured in yellow and shown in front of a dark background.
© HZI/Manfred Rohde

A bright spot for microbiological diagnostics

The detection of bacterial pathogens in clinical samples is an important prerequisite for successful antimicrobial treatment. A team from the German Center for Infection Research (DZIF), the Helmholtz

Newborn baby wearing only a diaper lying face-down on the skin of a person
© Photo by drz on Unsplash

Exposure to antibiotics during birth by caesarean section may increase infants’ long-term health risks

Animal studies indicate that prenatal contact with antibiotics can affect the early development of intestinal flora and lead to serious long-term health problems in offspring. In a pilot study

Visualisation of luminous strands of DNA as well as of a ring that depicts the combined analysis of many different bacterial genomes.
© Leon Kokkoliadis, Eberhard Karls Universität Tübingen

Only three percent of potential bacterial drug sources known

The emergence of antibiotic-resistant pathogens and the increasing difficulty in developing new drugs has contributed to global challenges in combating infectious diseases. An extensive bioinformatics

Samira Marx and Prof Gunther Hartmann
© Foto: David Fußhöller, Universität Bonn

New strategy to protect from severe COVID-19

SARS-CoV-2 viruses can hide from recognition by the immune system when infecting cells, thereby delaying the onset of the immune response. Scientists around Prof Gunther Hartmann from the University

Helicobacter flagellum
© Christine Josenhans and Shin-Ichi Aizawa, LMU

Bacterial shackle: Motility-inhibiting active substances against the gastric germ Helicobacter pylori

Helicobacter pylori, one of the most widespread bacterial pathogens, is responsible for hundreds of thousands of cases of stomach ulcers and stomach cancer worldwide every year. Due to increasing

Tuberculosis patients
© Christoph Lange

Tuberculosis: Different types of immunity determine the course of the disease

An international research team has succeeded in characterising different immune responses of tuberculosis patients and identifying groups of patients who either showed a very low or a very strong

Louisa Ruhl und Christine Falk
© MHH/K.Kaiser

How a SARS-CoV-2 infection can become severe COVID-19

Infection with SARS-CoV-2 leaves some people almost unaffected, while others develop life-threatening COVID-19 symptoms. So far, we do not understand exactly why symptoms and disease severity